Use of Bevacizumab in the Treatment of Metastatic Colorectal Cancer (mCRC) in Italy: an Observational Cohort Study
N/A
18 Years
N/A
18 Years
N/A
Open (Enrolling)
Both
Colorectal Cancer
Both
Colorectal Cancer
Trial Information
Use of Bevacizumab in the Treatment of Metastatic Colorectal Cancer (mCRC) in Italy: an Observational Cohort Study
Inclusion Criteria:
- Adult patients, >/= 18 years of age
- Metastatic colorectal cancer
- Having initiated first-line treatment with fluoropyrimidine-based chemotherapy plus
Avastin between 1. September 2011 and 29. February 2012
- Availability of test fro K-RAS genotyping
Exclusion Criteria:
- Participation in a clinical trial during treatment with Avastin
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Proportion of patients with Avastin treatment discontinuation due to either disease progression or Avastin-related adverse events
Outcome Time Frame:
approximately 15 months
Safety Issue:
No
Principal Investigator
Clinical Trials
Investigator Role:
Study Director
Investigator Affiliation:
Hoffmann-La Roche
Authority:
Italy: Ministry of Health
Study ID:
ML27907
NCT ID:
NCT01609075
Start Date:
June 2012
Completion Date:
May 2013
Related Keywords:
- Colorectal Cancer
- Colorectal Neoplasms
Name | Location |
|---|
